Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Dr. Chiadi Ndumele is the Director of Obesity and Cardiometabolic Research, Director of the Heart Failure Prevention Program and Associate Professor of Medicine and Epidemiology in the Division of Cardiology at Johns Hopkins University. Dr. Ndumele is a preventive cardiologist with doctorate level training in epidemiology, who leads a research program related to characterizing the relationship of obesity and cardiometabolic risk factors with the development of cardiovascular disease, with a particular focus on heart failure risk, and to refining strategies for cardiovascular disease prevention. His work additionally addresses the impact of social determinants of health on cardiometabolic risk factors and downstream cardiovascular outcomes. Dr. Ndumele received his M.D. from Harvard University and his Internal Medicine training at Brigham and Women’s Hospital, where he also served as Chief Medical Resident. He subsequently trained in Cardiology at Johns Hopkins University, where he was also Chief Cardiology Fellow in his final year and where he also received his MHS and PhD in Epidemiology. Dr. Ndumele’s research has been supported by multiple grants from the NIH, Robert Wood Johnson Foundation and the American Heart Association (AHA). He is Chair of the Council on Lifestyle and Cardiometabolic Health of the AHA, Past Chair of the AHA Obesity Committee, and Co-Chair of the AHA Cardiovascular-Kidney-Metabolic Health Initiative. Dr. Ndumele is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Atherosclerosis, Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), and Metabolic Syndrome.

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Peripartum Cardiomyopathy, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Pankaj Lal is a Cardiologist in Gaithersburg,, Maryland. Dr. Lal is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Stable Angina, Metabolic Syndrome, Fainting, and Angina.

Ayim Akyea is a Cardiologist in Beltsville, Maryland. Dr. Akyea is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Stable Angina, Metabolic Syndrome, Fainting, and Glucocorticoid-Remediable Aldosteronism.

Tracy Dodd, M.D., Ph.D., completed her Internal Medicine residency at Johns Hopkins Hospital in the urban health primary care track. She earned her Bachelor of Science and Doctor of Philosophy in Basic Medical Sciences from University of South Alabama, College of Medicine. She received her Doctor of Medicine degree from Louisiana State University, School of Medicine in New Orleans. Dr. Dodd is committed to utilizing all of the tools necessary to care for her patients. Her expertise is caring for patients with chronic and complex medical issues. It is her goal to be an advocate for her patients and to ensure her patients are up to date on their preventive health screening. Dr. Dodd is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. Her top areas of expertise are Metabolic Syndrome and Angioplasty.

Dr. Joao Lima is a professor of medicine, radiology and epidemiology at the Johns Hopkins School of Medicine. His pioneering work in cardiac imaging using advanced MRI, CT and echocardiography has led to noninvasive techniques for predicting cardiovascular disease and calculating its extent, as well as measuring the effectiveness of modern cardiac treatments. He holds numerous patents on devices and methods for cardiac imaging and image-guided therapies. Dr. Lima graduated medical school at the University of Bahia, Brazil. He completed his cardiology fellowship at Johns Hopkins and spent two years on the faculty of the University of Pennsylvania before returning to Hopkins as a faculty member in 1992. A long-time investigator with the Multi-Ethnic Study of Atherosclerosis (MESA), Dr. Lima is credited with more than 175 articles out of that study and nearly 575 publications over his career. He is associate editor of Journal of the American College of Cardiology and serves on the editorial board of the Italian Journal of Cardiology while reviewing for other journals including the New England Journal of Medicine, Circulation and Annals of Internal Medicine. Dr. Lima has been invited to present his research throughout the Americas, Europe and Asia. Dr. Lima is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Atherosclerosis, Heart Attack, Apoplexy, Heart Failure, and Bone Marrow Aspiration.

Rakesh Sahni is a Cardiologist in Greenbelt, Maryland. Dr. Sahni is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Metabolic Syndrome, Stable Angina, Angina, and Heart Murmurs.

Rene Desmarais is a Cardiologist in Salisbury,, Maryland. Dr. Desmarais is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Angina, Atherosclerosis, Coronary Heart Disease, Pacemaker Implantation, and Cardiac Ablation.

Nader Dakak is a Cardiologist in Glenn Dale, Maryland. Dr. Dakak is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Angina, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Hypertension.

Harikisan Heda is a Cardiologist in Salisbury,, Maryland. Dr. Heda is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Prinzmetal's Variant Angina, Coronary Artery Spasm, Angina, and Metabolic Syndrome.

Srinivas Addala is a Cardiologist in Clinton, Maryland. Dr. Addala is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Angina, Hypertensive Heart Disease, Coronary Heart Disease, and Atherosclerosis.

Sara Mekuria is a Cardiologist in Germantown, Maryland. Dr. Mekuria is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. Her top areas of expertise are Unstable Angina, Metabolic Syndrome, Familial Dilated Cardiomyopathy, and Angina.

Mark Treuth is a Cardiologist in Salisbury, Maryland. Dr. Treuth is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Coronary Heart Disease, Angina, Atherosclerosis, Atrial Fibrillation, and Pacemaker Implantation.

Gabriel Sardi is an Interventional Cardiologist in Cumberland, Maryland. Dr. Sardi is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Heart Attack, Apoplexy, Atrial Fibrillation, Percutaneous Coronary Intervention (PCI), and Angioplasty. Dr. Sardi is currently accepting new patients.

Barbara Hutchinson is a Cardiologist in Annapolis,, Maryland. Dr. Hutchinson is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. Her top areas of expertise are Metabolic Syndrome, Mitral Valve Regurgitation, Hypertension, and High Cholesterol.

Hassan Kassamali is a Cardiologist in Rosedale,, Maryland. Dr. Kassamali is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Hypertensive Heart Disease, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), His Bundle Tachycardia, Atrial Tachycardia, and Pacemaker Implantation.

Ramesh Agarwal is a Cardiologist in Salisbury, Maryland. Dr. Agarwal is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Angina, Coronary Heart Disease, Atherosclerosis, Stable Angina, and Pacemaker Implantation.

Anantha Rao is a Cardiologist in Hyattsville,, Maryland. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Apoplexy, Heart Attack, Unstable Angina, Cardiac Ablation, and Pacemaker Implantation.